Borges Luis
Known title: Chief Scientific OfficerCIK: 0001684015
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Century Therapeutics faces competitive pressure on key strategy. A recent analysis suggests that competitors are taking steps to reduce the risks associated with Century Therapeutics' primary business focus. This development is relevant as it may impact the company's market position and future prospects. The stock is currently trading near its support levels, reflecting ongoing uncertainty in the market.
Transaction History
| MGX | ▲ Buy | Grant | 69,316 | $0 | 4/1/2024 | View on chart |
| IPSC | ▲ Buy | Option Exercise | 7,452 | $8K | 4/3/2023 | View on chart |
| IPSC | ▲ Buy | Option Exercise | 220,930 | $228K | 3/23/2023 | View on chart |
| IPSC | ▼ Sell | Open Market | 15,597 | $55K | 3/23/2023 | View on chart |
| IPSC | ▲ Buy | Option Exercise | 65,698 | $68K | 3/22/2023 | View on chart |
| IPSC | ▼ Sell | Open Market | 65,698 | $245K | 3/22/2023 | View on chart |
| IPSC | ▼ Sell | Open Market | 63,616 | $240K | 3/21/2023 | View on chart |
| IPSC | ▲ Buy | Option Exercise | 63,616 | $66K | 3/21/2023 | View on chart |
| IPSC | ▲ Buy | Grant | 21,875 | $0 | 2/2/2023 | View on chart |
| IPSC | ▲ Buy | Grant | 21,875 | $0 | 2/2/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Metagenomi Therapeutics to Speak at Chardan Healthcare Conference
Metagenomi Therapeutics announced it will participate in the Chardan 10th Annual Healthcare Conference. This event provides a platform for the company to share updates with industry professionals and investors. The stock is currently trading near its 52-week low, making this upcoming presentation a notable point of interest for observers tracking the company's developments.
Metagenomi Therapeutics to Speak at Chardan Healthcare Conference. Metagenomi Therapeutics announced it will participate in the Chardan 10th Annual Healthcare Conference. This event provides a platform for the company to share updates with industry professionals and investors. The stock is currently trading near its 52-week low, making this upcoming presentation a notable point of interest for observers tracking the company's developments.